Medications used by children with asthma living in the inner city

Pediatrics

Volumn 101, Issue 3 I, 1998, Pages 349-354

  Eggleston, Peyton A ^a,d   Malveaux, Floyd J ^c   Butz, Arlene M ^b   Huss, Karen ^b   Thompson, Lera ^c   Kolodner, Ken ^a   Rand, Cynthia S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF NURSING   (United States)

^c HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Asthma; Epidemiology; Medications; Minorities

Indexed keywords

AMINOPHYLLINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CROMOGLYCATE DISODIUM; EPHEDRINE; STEROID;

ARTICLE; ASTHMA; DRUG CHOICE; HEALTH CARE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADRENERGIC BETA-AGONISTS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BALTIMORE; BRONCHODILATOR AGENTS; CHILD; CROSS-SECTIONAL STUDIES; DISTRICT OF COLUMBIA; DRUG UTILIZATION; FEMALE; HUMANS; MALE; POVERTY AREAS; QUESTIONNAIRES; SELF ADMINISTRATION; SEVERITY OF ILLNESS INDEX; THEOPHYLLINE; URBAN POPULATION;

EID: 0031881277     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.101.3.349     Document Type: Article

References (14)

1. National Asthma Education Program Expert Panel Report. Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: US Department of Health and Human Services; 1991. DHHS publication no. 91-3042
2. National Asthma Education Program: Expert Panel Report II. Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: US Department of Health and Human Services. 1997. Draft
3. Szefler SJ, Bender BG, Jusko WJ, Lanier BQ, Lemanske RF Jr, Skoner DP, Stempel DA. Evolving role of theophylline for the treatment of childhood asthma. J Pediatr. 1995;127:176-185
4. Sears MR, Taylor R. The β2 agonist controversy: observations, explanations and relationship to asthma epidemiology. Drug Saf. 1994;11: 259-283
5. Weiss KB, Wagener DK. Changing patterns of asthma mortality: identifying target populations at high risk. JAMA. 1990;264:1683-1688
6. Gergen PJ, Weiss KB. Changing patterns of asthma hospitalization among US children 0-17 years of age: 1979-87. JAMA. 1990;264:1688-1692
7. Evans R III, Mullaly DI, Wilson RW, et al. National trends in the morbidity and mortality of asthma in the United States. Chest. 1987;91: 65S-74S
8. Mak H, Johnston P, Abbey H, Talamo RC. Prevalence of asthma and health service utilization of asthmatic children in an inner city. J Allergy Clin Immunol. 1982;70:367-372
9. Halfon N, Newachek PW. Childhood asthma and poverty: differential impacts and utilization of health services. Pediatrics. 1993;91:56-61
10. Gerstman BB, Bosco LA, Tomita DK, Gross TP, Shaw MM. Prevalence and treatment of asthma in Michigan Medicaid patient population younger than 45 years, 1980-86. J Allergy Clin Immunol. 1989; 1032-1039
11. Homer CJ, Szilagyi P, Rodewald L, et al. Does quality of care affect rates of hospitalization for childhood asthma? Pediatrics. 1996;98:18-23
12. Finkelstein JA, Brown RW, Schneider LC, et al. Quality of care for preschool children with asthma: the role of social factors and practice setting. Pediatrics. 1995;95:389-394
13. Terr AI, Bloch DA. Trends in asthma therapy in the United States: 1965-1992. Ann Allergy. 1996;76:273-281
14. La Greca AM. Children with diabetes and their families: coping and disease management. In: Field TM, McCabe PM, Schneiderman N, eds. Stress and Coping Across Development. Hillsdale, NJ: Erlbaum; 1988: 139-159